Sequencing and analyzing human immune repertoires
V(D)J recombinations in lymphocytes are essential for immunological diversity. They are also useful markers of pathologies, and in leukemia, are used to quantify the minimal residual disease during patient follow-up. High-throughput sequencing (NGS/HTS) now enables the deep sequencing of a lymphoid population with dedicated sequencing methods and software, called either Rep-Seq or AIRR-Seq.
Library preparation and sequencing for human AIRR/RepSeq studies
Choosing library preparation and sequencing for immune repertoire analysis is a challenging task (Langerak 2017) and depends of multiple factors: aim of the study, people, sequencers, reagents, costs... We do not aim here to be authoritative, but give a few links to commonly used strategies for library preparation and sequencing.
PCR approaches are the state-of-the-art way to detect and quantify immune recombinations.
As of 2022, the reference protocols for library preparation on Illumina MiSeq using EuroClonality-NGS primers and analysis with Vidjil are described in (Villarese, 2022) (marker identification in ALL, 1-step, IGH FR2, IGH+, IGK/IGK+, TRB, TRB+, TRD/TRD+, TRG) and (de Septenville, 2022) (assessment of mutational status in CLL, 24+1 primers in 1 tube, IGHV-leader/IGHJ). They can be adapted for other sequencers.
The reference for EuroClonality-NGS primer sets are (Brüggemann, 2019) (2-step, 138 primers in 8 tubes, IGH FR1, IGH+, IGK, IGK+, TRB, TRB+, TRD/TRD+, TRG) and (Scheijen, 2019) (1-step, 53 primers in 3 tubes, IGH FR3, IGH+, IGK, IGK+). The EuroClonality-NGS consortium also published previous protocols for Illumina MiSeq and Ion Torrent.
Previously, many studies were successfully using primer sets based on the older EuroClonality/BIOMED-2 sets published in (van Dongen, 2003). See for example (Ferret, 2016) (1-step, 23 primers in 5 tubes, TRG, TRD/TRD+, IGK, IGK+).
These primer sets were designed and evaluated in multi-center validation studies for onco-hematological studies on lymphoma and/or leukemia samples, but may also be used in other studies on the immune repertoire. Such primer sets or DNA-Seq (or even on RNA-Seq) are very specific, leading to usually datasets with more than 90% or 99% of reads with V(D)J recombinations.
One-step approaches may be used even with the 2-steps primers, see (Brüggemann, 2019) for discussion. Some labs do sequence independently the tubes with barcoding, but for many applications the contents of the tubes can be pooled and sequenced at once. Using the full depth of a recent sequencer with spike-in control sequences, precise MRD quantification can be achieved (Knecht 2019). When the goal is only to detect a few dominant clones, many samples (10 to 100, or even more) can be pooled with proper barcoding in a same sequencing run. Contamination should then particularly be monitored.
Capture and other strategies
Several library preparations on DNA or RNA can be done with limited or no amplification: whole-genome or whole-transcriptome sequencing, capture, 5'RACE... Probes can possibly be designed in every V, D, or J gene, in the constant region, and/or consensus probes can be used. These methods can also be applied on single-cell sequencing, possibly with UMI identifiers.
One advantage of such libraries is that they can be combined to other studies, as for example with transcriptome analysis or probes targeting oncogenes or other sequences of interest. Of course, the downside is that non-recombined DNA or RNA are also sequenced: Depending on the method and the datasets, as few as between 0.001% and 0.1% reads will have an actual V(D)J recombination. With datasets with billions of reads, this is usally enough to detect dominant clones with something like a few hundred reads, but quantification is more limited. For such libraries, it may be worth to set up a post-sequencer workflow to work with smaller files.
When the read length is too short and the reads do not span the CDR3 and a few more nucleotides, some V(D)J recombinations may not be properly detected or designated.
As a rule of thumb, 100 bp centered around the CDR3 is usually enough to correctly identify most of the recombinations -- and many sequencing approaches today allow to have 300bp, 500bp or even much longer reads. However, even as few as 50 bp well-centered on the CDR3 usually detect many recombinations. The key point, depending on the library preparation, is thus what position the CDR3 is actually in the read.
Anyway, with short reads, the identified recombinations may be skewed towards shorter sequences, such as:
- more VJ than VDJ recombinations
- shorter N and more deleted D genes Those biases could occur inside one locus but also favor loci/systems with shorter recombinations
Analyzed human immune recombinations in Vidjil
Vidjil is an open-source platform for the analysis of high-throughput sequencing data from lymphocytes.
It was designed to detect all the common V(D)J recombinations,
even the incomplete/special recombinations occurring during the hematopoeisis
-- such recombinations systems are denoted with a
In particular, Vidjil-algo detects all the human recombinations targeted by the EuroClonality-NGS (2019) and the EuroClonality/BIOMED-2 (2003) primer sets. Vidjil-algo currently analyzes the following recombinations, selecting the best locus for each read.
|complete recombinations||incomplete/special recombinations|
|TRD||Vd-(Dd)-Jd||TRD+||Vd-Dd3, Dd2-(Dd)-Jd, Dd2-Dd3|
When using Vidjil-algo through the command-line, the configuration of analyzed recombinations is done in the
The detection of complete recombinations is reliable provided the reads are long enough around the V(D)J junction (see above).
The detection of incomplete/special recombinaisons is more challenging and may fail in some cases. In particular, as D genes may be very short, detecting TRD+ (Dd2/Dd3) and IGH+ (Dh-Jh) recombinations require to have reads with fairly conserved D genes or up/downstream regions.
-2 command line option and the
multi+inc+xxx server configuration try to
detect unexpected or chimeric recombinations between genes of different germlines or on different
strands (such as PCR dimers or +V/-V recombinations).
These recombinations, tagged as
xxx, can be technological artefacts or unusual biological recombinations.
Finally, the experimental
--find command line option detect non-recombined known sequences,
and may be used for
standards/spikes, spurious adaptors,
CD or other sequences in RNA-seq data,
unrecombined V/J sequences, or heptamers/nonamers/RSS.
Note that the Vidjil web application can also display recombinations detected by other software,
as long as this information is provided in the
.vidjil file computed by such other software.